youtube_live
Q3 2026 earnings • released • EPS beat +8.62% • Revenue beat +2.31%
See resultschevron_right
EW:NYSE
Edwards Lifesciences Corp
$99.37
arrow_upward
+4.38%(+4.17) 1D
$103.22
arrow_upward
+3.87% (+3.85)todayPre-market
Closed: Nov 4, 4:00:04 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
$98.58
High
$100.25
Low
$96.72
Mkt. cap
57.28B
Avg. vol.
4.00M
Volume
988.00
P/E ratio
57.49
52-wk high
$100.25
52-wk low
$74.66
EPS
$1.73
Beta
0.85
Shares outstanding
576.40M
No. of employees
16K
Open
$98.58
High
$100.25
Low
$96.72
Mkt. cap
57.28B
Avg. vol.
4.00M
Volume
988.00
P/E ratio
57.49
52-wk high
$100.25
52-wk low
$74.66
EPS
$1.73
Beta
0.85
Shares outstanding
576.40M
No. of employees
16K
News stories
From web sources and news partners
Investing.com
·
11 minutes ago
Wells Fargo raises Edwards Lifesciences price target on Q3 beat
BigGo Finance
·
10 hours ago
[Edwards Lifesciences Q3 2026 Earnings Call] Edwards Raises Full-Year Guidance to 11.5% Sales Growth and $3.01 EPS Midpoint After Q3 Beat; TAVR Growth to Rely on Market Expansion, Not Share Gains
GuruFocus
·
11 hours ago
Edwards Lifesciences (EW) Q3 Earnings Beat Expectations, Raises Guidance
Benzinga
·
12 hours ago
Edwards Lifesciences Q3 2026 Earnings Call Transcript
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16K
Founded1958
HeadquartersIrvine, California, United States
SectorMedical device
Industry-
Websiteedwards.com